Login to Your Account



NewCo News

BioMoti Closes Round to Advance Microparticle Platform

By Nuala Moran
Staff Writer

Wednesday, February 27, 2013
LONDON – Start-up BioMoti Ltd. secured its first private financing in a seed round of £150,000 (US$227,000) to advance its Oncojan platform technology, a microparticle carrier system combining targeted delivery of chemotherapy drugs with their controlled release within tumor cells.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription